Last updated: 11/07/2018 18:59:27
(SCAB1001): Report for a study to investigate whether multiple oral doses of lamotrigine affect the pharmacokinetic of multiple oral doses of Lithium in healthy volunteers.
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: (SCAB1001): Report for a study to investigate whether multiple oral doses of lamotrigine affect the pharmacokinetic of multiple oral doses of Lithium in healthy volunteers.
Trial description: (SCAB1001): Report for a study to investigate whether multiple oral doses of lamotrigine affect the pharmacokinetic of multiple oral doses of Lithium in healthy volunteers.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Abstract: Lamotrigine does not cause clinically relevant changes in the pharmacokinetics of lithium. Veronese, L., Chen, C., and Peck, R. 11th European College of Neuropsychopharmacology Congress (ECNP) 10/31/1998 Paris; France
Chen C, Veronese L, Yin Y. The effects of lamotrigine on the pharmacokinetics of lithium. British Journal of Clinical Pharmacology 2000;50:193-195.
Medical condition
Bipolar Disorder
Product
lamotrigine
Collaborators
Not applicable
Study date(s)
March 1997 to April 1997
Type
Not applicable
Phase
1
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1997-15-04
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website